More recently, it is reported that both antibodies and T cells are generated in response to aberrant cyclin B1 expression in tumors like breast cancer [12,13], indicating that overexpressed cyclin B1 could serve as one of the signals to initiate the communication between cancer cells and their microenvironment. Here, CCNB1 is linked to breast carcinoma.